PIII Earnings P3 Health Partners Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–22 of 22
| Q2 2026 | 2026-06-30 | -0.63 | 2026-08-10 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.32 | 2026-05-14 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -23.08 | 2026-03-26 | 10-K |
| FY 2024 | 2025-12-31 | -45.26 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -9.67 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -6.23 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -6.28 | 2025-05-15 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -23.13 | 2025-03-28 | 10-K |
| FY 2024 | 2024-12-31 | -54.06 | 2025-03-28 | 10-K |
| Q3 2024 | 2024-09-30 | -15.70 | 2024-11-12 | 10-Q |
| Q2 2024 | 2024-06-30 | -7.37 | 2024-08-07 | 10-Q |
| Q1 2024 | 2024-03-31 | -7.86 | 2024-05-08 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -10.00 | 2024-03-28 | 10-K |
| FY 2023 | 2023-12-31 | -31.50 | 2024-03-28 | 10-K |
| Q3 2023 | 2023-09-30 | -6.00 | 2023-11-08 | 10-Q |
| Q2 2023 | 2023-06-30 | -4.50 | 2023-08-07 | 10-Q |
| Q1 2023 | 2023-03-31 | -11.00 | 2023-05-10 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -112.50 | 2023-03-31 | 10-K |
| FY 2022 | 2022-12-31 | -325.00 | 2023-03-31 | 10-K |
| Q3 2022 | 2022-09-30 | -13.50 | 2022-11-14 | 10-Q |
| Q2 2022 | 2022-06-30 | -186.50 | 2022-10-21 | 10-Q |
| Q1 2022 | 2022-03-31 | -12.50 | 2022-10-21 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.